Roble Belko & Company’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3K Hold
25
﹤0.01% 314
2025
Q1
$3K Hold
25
﹤0.01% 301
2024
Q4
$4K Sell
25
-25
-50% -$4K ﹤0.01% 279
2024
Q3
$10K Hold
50
﹤0.01% 231
2024
Q2
$12K Hold
50
﹤0.01% 230
2024
Q1
$11K Hold
50
﹤0.01% 239
2023
Q4
$13K Hold
50
﹤0.01% 225
2023
Q3
$13K Hold
50
﹤0.01% 203
2023
Q2
$14K Hold
50
﹤0.01% 204
2023
Q1
$14K Hold
50
﹤0.01% 212
2022
Q4
$14K Hold
50
﹤0.01% 232
2022
Q3
$13K Hold
50
﹤0.01% 225
2022
Q2
$10K Hold
50
﹤0.01% 241
2022
Q1
$11K Hold
50
﹤0.01% 280
2021
Q4
$12K Hold
50
﹤0.01% 255
2021
Q3
$14K Hold
50
﹤0.01% 229
2021
Q2
$17K Hold
50
﹤0.01% 232
2021
Q1
$14K Hold
50
﹤0.01% 234
2020
Q4
$12K Hold
50
﹤0.01% 229
2020
Q3
$14K Hold
50
﹤0.01% 210
2020
Q2
$13K Hold
50
﹤0.01% 233
2020
Q1
$16K Hold
50
0.01% 206
2019
Q4
$15K Hold
50
﹤0.01% 238
2019
Q3
$12K Hold
50
﹤0.01% 245
2019
Q2
$12K Sell
50
-10
-17% -$2.4K ﹤0.01% 241
2019
Q1
$14K Hold
60
﹤0.01% 192
2018
Q4
$18K Hold
60
0.01% 158
2018
Q3
$21K Hold
60
0.01% 158
2018
Q2
$17K Sell
60
-1,236
-95% -$350K 0.01% 174
2018
Q1
$355K Buy
1,296
+23
+2% +$6.3K 0.14% 42
2017
Q4
$406K Buy
1,273
+135
+12% +$43.1K 0.17% 40
2017
Q3
$356K Sell
1,138
-250
-18% -$78.2K 0.16% 38
2017
Q2
$377K Hold
1,388
0.18% 38
2017
Q1
$380K Sell
1,388
-130
-9% -$35.6K 0.19% 37
2016
Q4
$430K Sell
1,518
-334
-18% -$94.6K 0.23% 35
2016
Q3
$580K Buy
1,852
+29
+2% +$9.08K 0.31% 34
2016
Q2
$441K Buy
1,823
+90
+5% +$21.8K 0.24% 36
2016
Q1
$451K Buy
1,733
+17
+1% +$4.42K 0.26% 35
2015
Q4
$526K Hold
1,716
0.32% 35
2015
Q3
$501K Hold
1,716
0.31% 36
2015
Q2
$693K Hold
1,716
0.4% 35
2015
Q1
$725K Buy
+1,716
New +$725K 0.42% 35